Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06729697

Pharmaceutical Literacy and Quality of Life in Spanish Population.

Pharmaceutical Literacy in Spanish Population and Association With Health-Related Quality of Life

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,246 (estimated)
Sponsor
University of Barcelona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to learn about the knowledge and abilities that patients have regarding their own medication and to see if that's related to their quality of life. The main questions it aims to answer are: * Are patients abilities and knowledge about their medications sufficient to ensure a safe and efective use? * Are those knowledge and abilities related to the patient's quality of life? How? Patients already taking at least one medication will answer questions about their abilities and knowledge towards medication and their quality of life related to their health state.

Detailed description

A cross-sectional study is carried out, consisting of an interview between the patients and community pharmacists included in the study. The participants selected are adults usually taking medication that answer questions related to their pharmaceutical literacy (RALPH interview). This type of literacy refers to three domains regarding functional, comunicative and critical abilities about their own medication. After that, every participant answers a simple survey regarding their health-related quality of life including topics such as mobility, self-care, everyday activities, pain and mental health (EQ-5D-5L survey). The recruitment and interviewing take place at the same time, and it requires less than 30 minutes per patient. No follow-up is needed afterward. There are no risks associated with this procedure, and the participation of the patients will always be voluntary and anonymous. Previously to the patients' enrollment in the study, proper information will be given to the potential participants and an informed consent will be signed.

Conditions

Timeline

Start date
2024-11-15
Primary completion
2025-06-30
Completion
2025-07-30
First posted
2024-12-11
Last updated
2025-04-13

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06729697. Inclusion in this directory is not an endorsement.